Projects overview

Sort by

Toggle all information

XVR011 Phase 2 | ExeVir's XVR011, a best in class nanobody-based biology that broadly neutralizes SARS-COV-1 and SARS-COV-2

01-12-2021

-

30-11-2022

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2021-CORONA-01
HORIZON-HLTH-2021-CORONA-01-01 Vaccines & therapeutic clinical trials to boost COVID-19 prevention and treatment

COVend | Biomarker and AI-supported FX06 therapy to prevent progression from mild and moderate to severe stages of COVID-19

01-08-2021

-

31-01-2025

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2021-CORONA-01
HORIZON-HLTH-2021-CORONA-01-01 Vaccines & therapeutic clinical trials to boost COVID-19 prevention and treatment

RBDCOV | RBD Dimer recombinant protein vaccine against SARSCoV2

01-12-2021

-

31-08-2025

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2021-CORONA-01
HORIZON-HLTH-2021-CORONA-01-01 Vaccines & therapeutic clinical trials to boost COVID-19 prevention and treatment
Powered by Chris Decubber BV